Kasim S, Bessman A
Diabetologia. 1984 Jul;27(1):59-61. doi: 10.1007/BF00253504.
Four hundred and forty-nine patients with Type 2 (non-insulin-dependent) diabetes mellitus and 270 control subjects from Caucasoid, Mexican and black origins were screened for the presence of thyroid microsomal antibodies. Mexican female control subjects had a significantly higher frequency of thyroid microsomal antibodies when compared with black female controls (21% versus 6%, p less than 0.01). Type 2 diabetic patients did not have a higher frequency of thyroid microsomal antibodies when compared with their sex- and race-matched control counterparts. The subgroup of diabetic patients who required insulin for the control of their blood glucose did not have a higher frequency of thyroid microsomal antibodies when compared with non-insulin-requiring diabetic patients. In conclusion autoimmunity against thyroid gland, as manifested by thyroid microsomal antibodies, is not more common in Type 2 diabetic patients when compared with sex- and race-matched control subjects.
对449例2型(非胰岛素依赖型)糖尿病患者以及270名来自白种人、墨西哥裔和黑人的对照受试者进行了甲状腺微粒体抗体检测。与黑人女性对照相比,墨西哥女性对照受试者的甲状腺微粒体抗体频率显著更高(21%对6%,p<0.01)。与性别和种族匹配的对照受试者相比,2型糖尿病患者的甲状腺微粒体抗体频率并未更高。与不需要胰岛素的糖尿病患者相比,需要胰岛素来控制血糖的糖尿病患者亚组的甲状腺微粒体抗体频率也没有更高。总之,与性别和种族匹配的对照受试者相比,2型糖尿病患者中由甲状腺微粒体抗体所表现出的针对甲状腺的自身免疫并不更常见。